Clinical Trials Browser

Phase 1 × Recruiting × disitamab vedotin × Clear all

NCT05940896 2023-11-27

RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor